Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Veziris

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
La Revue Du Praticien|May 31, 2012
[Bacteriological diagnosis of tuberculosis]Nicolas Veziris
Medecine Sciences : M/S|March 21, 2023
[Tuberculosis: New findings on an old infectious disease]Alexandra Aubry, Nicolas Veziris
Medecine Sciences : M/S|November 26, 2010
[Anti-tuberculosis drug resistance and therapeutic dead end]Nicolas Veziris, Jérôme Robert
American Journal of Respiratory and Critical Care Medicine|June 19, 2019
Smear Microscopy Complements Xpert MTB/RIF When Considering Nontuberculous Mycobacterial InfectionsAlexandra Aubry, Nicolas Veziris
Chemotherapy|April 1, 2015
French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS(®) in MDR-TB patientsYves Kibleur, Nicolas Veziris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
Good interpretation of the results of a diagnostic testNicolas Veziris, Vincent Jarlier
Plos One|July 3, 2014
Unbiased estimation of mutation rates under fluctuating final countsBernard Ycart, Nicolas Veziris
The European Respiratory Journal|April 2, 2021
Defining optimal fluoroquinolone exposure against <i>Mycobacterium tuberculosis</i>: contribution of murine studiesThomas Maitre, Lorenzo Guglielmetti, Nicolas Veziris
The New England Journal of Medicine|December 15, 2017
Molecular Drug-Susceptibility Test for TuberculosisThomas Maitre, Alexandra Aubry, Nicolas Veziris
Plos One|March 14, 2017
Correction: Unbiased Estimation of Mutation Rates under Fluctuating Final CountsAdrien Mazoyer, Bernard Ycart, Nicolas Veziris
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
La Revue Du Praticien|May 31, 2012
[Bacteriological diagnosis of tuberculosis]Nicolas Veziris
Medecine Sciences : M/S|March 21, 2023
[Tuberculosis: New findings on an old infectious disease]Alexandra Aubry, Nicolas Veziris
Medecine Sciences : M/S|November 26, 2010
[Anti-tuberculosis drug resistance and therapeutic dead end]Nicolas Veziris, Jérôme Robert
American Journal of Respiratory and Critical Care Medicine|June 19, 2019
Smear Microscopy Complements Xpert MTB/RIF When Considering Nontuberculous Mycobacterial InfectionsAlexandra Aubry, Nicolas Veziris
Chemotherapy|April 1, 2015
French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS(®) in MDR-TB patientsYves Kibleur, Nicolas Veziris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
Good interpretation of the results of a diagnostic testNicolas Veziris, Vincent Jarlier
Plos One|July 3, 2014
Unbiased estimation of mutation rates under fluctuating final countsBernard Ycart, Nicolas Veziris
The European Respiratory Journal|April 2, 2021
Defining optimal fluoroquinolone exposure against <i>Mycobacterium tuberculosis</i>: contribution of murine studiesThomas Maitre, Lorenzo Guglielmetti, Nicolas Veziris
The New England Journal of Medicine|December 15, 2017
Molecular Drug-Susceptibility Test for TuberculosisThomas Maitre, Alexandra Aubry, Nicolas Veziris
Plos One|March 14, 2017
Correction: Unbiased Estimation of Mutation Rates under Fluctuating Final CountsAdrien Mazoyer, Bernard Ycart, Nicolas Veziris
Pageof 12